Turn Therapeutics Inc.
TTRXNasdaqCIK 2023016HealthcareFiscal year ends Dec 31
Reports and events: 36 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1920:05 ET | DEF 14A | Proxy statementPeriod 2026-11-30 | 0001213900-26-110670 |
| 2026-10-0723:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-107329 |
| 2026-09-1012:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-098584 |
| 2026-09-0912:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-098224 |
| 2026-08-1812:30 ET | 8-K | 3.02 Unregistered sale of equity | 0001213900-26-091002 |
| 2026-08-1720:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-090766 |
| 2026-08-1220:50 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-088427 |
| 2026-08-1220:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-088411 |
| 2026-07-2812:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-081996 |
| 2026-07-0712:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-075757 |
| 2026-06-0310:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-064405 |
| 2026-06-0112:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-063177 |
| 2026-05-2712:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-061244 |
| 2026-05-1912:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-058730 |
| 2026-05-1812:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-058140 |
| 2026-05-1120:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-054490 |
| 2026-05-1120:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-054480 |
| 2026-03-3120:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-037505 |
| 2026-03-3120:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-037470 |
| 2026-03-2412:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-033233 |
| 2026-02-1713:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-016916 |
| 2026-02-0913:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-013490 |
| 2026-01-1213:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-003153 |
| 2026-01-0721:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-002173 |
| 2025-11-1313:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109586 |
| 2025-11-1313:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-109580 |
| 2025-11-1212:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-108655 |
| 2025-11-0422:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-106265 |
| 2025-10-3011:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-104028 |
| 2025-10-2820:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-103160 |
| 2025-10-2212:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-101410 |
| 2025-10-0920:15 ET | S-1 | Registration statement | 0001104659-25-098363 |
| 2025-10-0218:15 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-096003 |
| 2025-09-2421:16 ET | S-1/A | Registration statement, amended | 0001104659-25-092994 |
| 2025-09-1621:09 ET | S-1/A | Registration statement, amended | 0001104659-25-090474 |
| 2025-09-0200:31 ET | S-1 | Registration statement | 0001104659-25-085850 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.